Preoperative steroid in abdominal wall reconstruction: protocol for a randomised trial

Area of Science:

• Surgical innovation
• Clinical trial methodology
• Patient recovery optimization

Background:

• Preoperative high-dose glucocorticoids are linked to better recovery and shorter hospital stays in abdominal surgery.
• Limited research exists on glucocorticoid use in abdominal wall reconstruction (AWR) for giant ventral hernias, potentially due to concerns about wound healing.
• This study addresses the gap by examining glucocorticoid benefits in AWR patients.

Purpose of the Study:

• To evaluate the efficacy of preoperative glucocorticoid administration in patients undergoing AWR for large ventral hernias.
• To determine if methylprednisolone improves postoperative pain and recovery compared to a placebo.
• To assess the impact of glucocorticoids on wound healing and other complications in this patient cohort.

Main Methods:

• A randomized controlled trial involving 40 patients with ventral hernias (fascial defect >10 cm).
• Patients received either intravenous methylprednisolone (125 mg) or saline at anesthesia induction.
• Primary endpoint: postoperative pain at rest on day one. Secondary outcomes: subjective measures, wound complications, and fluid analysis over 30 days.

Main Results:

• This is the first trial assessing preoperative glucocorticoids in AWR patients.
• The study provides crucial data on potential benefits for a patient group with significant postoperative challenges.
• Findings may elucidate the role of glucocorticoids in hernia repair wound healing.

Conclusions:

• Preoperative glucocorticoid administration warrants further investigation for AWR patients.
• This patient group, prone to prolonged recovery and complications, may significantly benefit from such interventions.
• Understanding glucocorticoid effects on wound healing is vital for optimizing outcomes in hernia repair surgery.